Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial

BACKGROUND: Germ cell tumors (GCT) are the most common solid tumors in adolescent and young adult males (age 15 and 35 years) and remain one of the most curable of all solid malignancies. However a subset of patients will have tumors that are refractory to standard chemotherapy agents. The managemen...

Descripción completa

Detalles Bibliográficos
Autores principales: Subbiah, Vivek, Meric-Bernstam, Funda, Mills, Gordon B, Shaw, Kenna R Mills, Bailey, Ann Marie, Rao, Priya, Ward, John F, Pagliaro, Lance C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237879/
https://www.ncbi.nlm.nih.gov/pubmed/25085632
http://dx.doi.org/10.1186/s13045-014-0052-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237879/
https://www.ncbi.nlm.nih.gov/pubmed/25085632
http://dx.doi.org/10.1186/s13045-014-0052-x

Ejemplares similares